Heart failure (HF) patients who have reduced or mildly reduced ejection fraction derive better outcomes when low-dose digoxin ...
A “pace and ablate” approach has been shown to be effective in patients with symptomatic, refractory AF. Guidelines currently ...
A meta-analysis confirms what’s known: physiology-guided PCI is “not a survival treatment” when compared with OMT.
The Bioadaptor coronary implant (Elixir Medical) continues to outperform contemporary drug-eluting stent technology over ...
The data reflect a high degree of technical success, clinical efficacy, and safety of the new technique, says Gennaro ...
There are still some kinks to be ironed out, including risks of hemolysis and valve thrombosis, to put things on par with ...
Top-line results from the phase III trial show average weight losses of 19% to 28.3% by 80 weeks depending on dose.
Adverse pregnancy outcomes were linked to higher BP, BMI, and other cardiometabolic risk factors in kids 20 years later.
The totality of data suggests that routine PCI prior to TAVI is not warranted in the majority of cases, a meta-analysis shows ...
While the age-specific analysis was welcome, some felt it didn’t dig deep enough and others questioned the bleeding endpoints ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results